W. Mullally
Director/Board Member at THIOGENESIS THERAPEUTICS, CORP.
Net worth: 448 875 $ as of 31/05/2024
Profile
W.
Hogan Mullally is the founder of Sectorspeak, Inc. (founded in 2008) where he holds the title of President.
He is currently working as a Director at Thiogenesis Therapeutics, Inc. and as an Independent Director at Thiogenesis Therapeutics Corp.
He has previously worked as a Director-Investor Relations at Medicure, Inc. (2005-2008), as a Director at Rozdil Capital Corp., as a Vice President-Investor Relations at Functional Technologies Corp.
(2008-2012), and as the Head-Pharmaceutical Sales & Marketing at Bausch & Lomb (Australia) Pty Ltd.
(1999-2001).
Mr. Mullally holds an MBA from Asper School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/08/2023 | 875,000 ( 2.10% ) | 448 875 $ | 31/05/2024 |
W. Mullally active positions
| Companies | Position | Start |
|---|---|---|
| THIOGENESIS THERAPEUTICS, CORP. | Director/Board Member | 03/05/2018 |
| Sectorspeak, Inc. | Founder | 01/03/2008 |
Former positions of W. Mullally
| Companies | Position | End |
|---|---|---|
| ROZDIL CAPITAL CORPORATION | Director/Board Member | 18/04/2022 |
| MEDICURE INC. | Public Communications Contact | 01/01/2008 |
Bausch & Lomb (Australia) Pty Ltd.
 Bausch & Lomb (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Bausch & Lomb Australia Pty Ltd. manufactures and distributes prescription medicines. It offers consumer healthcare, prescription, aesthetic skin and eyecare. The company was founded in 2006 and is headquartered in Chatswood, Australia. | Sales & Marketing | 01/01/2001 |
| FUNCTIONAL TECHNOLOGIES CORP | Investor Relations Contact | - |
Training of W. Mullally
| Asper School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| THIOGENESIS THERAPEUTICS, CORP. | Finance |
| MEDICURE INC. | Health Technology |
| Private companies | 4 |
|---|---|
Rozdil Capital Corp.
 Rozdil Capital Corp. Financial ConglomeratesFinance Rozdil Capital Corp. operates as a capital pool company. It is engaged in the identification and evaluation of assets or businesses with a view to completing a Qualifying Transaction. The company was founded on May 3, 2018 and is headquartered in Toronto, Canada. | Finance |
| Sectorspeak, Inc. | |
Functional Technologies Corp.
 Functional Technologies Corp. Food: Major DiversifiedConsumer Non-Durables Functional Technologies Corp. develops and commercializes proprietary, yeast-based solutions in the food, beverage and healthcare industries. Its technologies include yeasts that prevent and reduce the formation of foul-smelling hydrogen sulphide and carcinogen and acrylamide, both by-products of food and beverage processing. The company was founded by Howard J. Louie and Geoffrey Conrad Lee on October 18, 1999 and is headquartered in Vancouver, Canada. | Consumer Non-Durables |
Bausch & Lomb (Australia) Pty Ltd.
Bausch & Lomb (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Bausch & Lomb Australia Pty Ltd. manufactures and distributes prescription medicines. It offers consumer healthcare, prescription, aesthetic skin and eyecare. The company was founded in 2006 and is headquartered in Chatswood, Australia. | Health Technology |
- Stock Market
- Insiders
- W. Mullally
